Envision Eye Centre 2019 Interactive Optometry Night
Date: 5/03/2019
Venue: Swissotel Sydney 68 Market Street, NSW, 2000
Provider: Envision Eye Centre
Contact: Ursula Kunicki, [E] surgical@corneaclinic.com.au, [P] (02) 9233 7333
Learning Objectives
- Objective 1: At the completion of the CPD activity, participants should be able to understand how to perform an examination of the intraocular lens, assessing for typical complications including malpositioning, dislocation, and opacification
- Objective 2: At the completion of the CPD activity, participants should be able to discuss strategies for the treatment of common intraocular lens complications including conservative and surgical methods
- Objective 3: At the completion of the CPD activity, participants should be able to understand and discuss when to refer intraocular lens-related problems for further review and consideration of further treatment
- Objective 4: At the completion of the CPD activity, participants should be able to make an informed decision as to whether it is worth screening for keratoconus.
- Objective 5: At the completion of the CPD activity, participants should be able to understand the potential of screening methods for keratoconus
- Objective 6: At the completion of the CPD activity, participants should be able to display a good understanding of both the benefits and limitations of screening for keratoconus.
- Objective 7: At the completion of the CPD activity, participants should be able to understand the different types of penetrating eye injury.
- Objective 8: At the completion of the CPD activity, participants should be able to identify signs of penetrating eye injury.
- Objective 9: At the completion of the CPD activity, participants should be able to understand the basic principles of managing penetrating eye injury.
- Objective 10: At the completion of the CPD activity, participants should be able to identify common eyelid malpositions and the surgical treatment associated with these conditions
- Objective 11: At the completion of the CPD activity, participants should be able to understand common benign and malignant eyelid lesions and the surgical management associated with this.
- Objective 12: At the completion of the CPD activity, participants should be able to understand the difficulties associated with Epiphora (watery eye) and management of this condition
- Objective 13: At the completion of the CPD activity, participants should be able to have an update on Medicare requirements on certain Oculoplastic items.
- Objective 14: At the completion of the CPD activity, participants should be able to have a good understanding of current diagnosis and treatments for macular degeneration.
- Objective 15: At the completion of the CPD activity, participants should be able to have a higher level of understanding of how Artificial Intelligence can help with the diagnosis of ARMD
- Objective 16: At the completion of the CPD activity, participants should be able to have more insight into new treatments being trialed for ARMD
- Objective 17: At the completion of the CPD activity, participants should be able to understand the epidemiology and clinical presentation of intermittent esotropia.
- Objective 18: At the completion of the CPD activity, participants should be able to have a greater understanding of the different classifications of intermittent esotropia.
- Objective 19: At the completion of the CPD activity, participants should be able to understand how to treat intermittent esotropia with non-surgical options.
Max points awarded: 6.00
Session Information
Name |
---|
Complications of Intraocular Lens Implantation |
Activity Type |
Face to Face without Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name |
---|
Screening for Keratoconus |
Activity Type |
Face to Face without Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name |
---|
Taking the Trauma out of Corneal Trauma |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name |
---|
Common Oculoplastic Conditions |
Activity Type |
Face to Face without Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name |
---|
Update on Macular Degeneration |
Activity Type |
Face to Face without Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name |
---|
Understanding Intermittent Esotropia |
Activity Type |
Face to Face without Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
---|---|---|---|---|
Complications of Intraocular Lens Implantation | Face to Face without Assessment | No | No | 1.00 |
Screening for Keratoconus | Face to Face without Assessment | No | No | 1.00 |
Taking the Trauma out of Corneal Trauma | Face to Face without Assessment | No | No | 1.00 |
Common Oculoplastic Conditions | Face to Face without Assessment | No | No | 1.00 |
Update on Macular Degeneration | Face to Face without Assessment | No | No | 1.00 |
Understanding Intermittent Esotropia | Face to Face without Assessment | No | No | 1.00 |